Abstract: Disclosed are a fiber for a sound-absorbing material for vehicles and a sound-absorbing material for vehicles including the same. The cross-section of the fiber for a sound-absorbing material includes a first end portion, a second end portion spaced apart from the first end portion, and an intermediate portion connected to the first end portion and the second end portion. The intermediate portion includes at least three bent portions. Each of the first end portion and the second end portion has a width larger than the width of the intermediate portion.

Abstract: The present invention relates to a hemostatic composition and a method for preparing thereof, and more specifically, relates to a hemostatic composition comprising a cross-linked hyaluronic acid derivative matrix which is suitable to be used for hemostasis and a method of preparation of such a composition.

Abstract: The present invention relates to a composition for treating osteoarthritis and a method for preparing the same, and more specifically, relates to a composition comprising hydrophilized sulfasalazine as an active ingredient and hyaluronic acid so as to enable effective treatment of osteoarthritis such as degenerative osteoarthritis by preventing joint wear in addition to symptom relief through intraarticular or local administration, and a method for preparing the same.

Abstract: Disclosed are a fiber for a sound-absorbing material for vehicles and a sound-absorbing material for vehicles including the same. The cross-section of the fiber for a sound-absorbing material includes a first end portion, a second end portion spaced apart from the first end portion, and an intermediate portion connected to the first end portion and the second end portion. The intermediate portion includes at least three bent portions. Each of the first end portion and the second end portion has a width larger than the width of the intermediate portion.

Abstract: The present invention relates to a composition for treating osteoarthritis and a method for preparing the same, and more specifically, relates to a composition comprising hydrophilized sulfasalazine as an active ingredient and hyaluronic acid so as to enable effective treatment of osteoarthritis such as degenerative osteoarthritis by preventing joint wear in addition to symptom relief through intraarticular or local administration, and a method for preparing the same.

Abstract: The present invention refers to the injectable hyaluronic acid composition which is crosslinked viscoelastic hyaluronic acid gel comprising DNA fractions. More particularly, it refers to the injectable hyaluronic acid composition comprising a hyaluronic acid composition crosslinked in the basic conditions with the degree of crosslinking between 0.1 and 200%, which is mixed with the DNA fractions of 0.1 to 50 wt %. The DNA fractions are selected, for example, from polynucleotide (PN) and polydeoxyribonucleotide (PDRN). The composition used for cosmetic purposes or therapeutic purposes, have improved viscoelastic rheological properties and enzyme resistance.

Abstract: The present invention relates to a hemostatic composition and a method for preparing thereof, and more specifically, relates to a hemostatic composition comprising a cross-linked hyaluronic acid derivative matrix which is suitable to be used for hemostasis and a method of preparation of such a composition.

Abstract: The present invention relates to a composition for treating osteoarthritis and a method for preparing the same, and more specifically, relates to a composition comprising hydrophilized sulfasalazine as an active ingredient and hyaluronic acid so as to enable effective treatment of osteoarthritis such as degenerative osteoarthritis by preventing joint wear in addition to symptom relief through intraarticular or local administration, and a method for preparing the same.

Abstract: The present invention refers to the injectable hyaluronic acid composition which is crosslinked viscoelastic hyaluronic acid gel comprising DNA fractions. More particularly, it refers to the injectable hyaluronic acid composition comprising a hyaluronic acid composition crosslinked in the basic conditions with the degree of crosslinking between 0.1 and 200%, which is mixed with the DNA fractions of 0.1 to 50 wt %. The DNA fractions are selected, for example, from polynucleotide (PN) and polydeoxyribonucleotide (PDRN). The composition used for cosmetic purposes or therapeutic purposes, have improved viscoelastic rheological properties and enzyme resistance.

Abstract: The present invention relates to an LED fluorescent lamp using far-infrared radiation without a heat sink. According to the present invention, a circuit is formed by peeling the copper foil layers on both sides of the non-metal double-sided PCB substrate. The area of the copper foil layer area on which LEDs are installed in series is maximized. The circuit components are mounted on the outside of the PCB, and the connection circuit is formed on a portion of the substrate surface in which the LEDs are not mounted. The LED fluorescent Lamp utilizes infrared emissivity to provide excellent heat dissipation even though a heat sink is not attached.

Abstract: This invention relates to a stable liquid formulation comprising hyaluronidase and a stabilizer for hyaluronidase and more particularly, to a stable liquid formulation by the addition of the stabilizer to the hyaluronidase.

Abstract: This invention relates to a stable hyaluronidase liquid formulation comprising a hyaluronidase and a stabilizer for hyaluronidase. In particular, the hyaluronidase has a purity of 95% or more and the specific activity of 70,000 IU/mg or more, and the stabilizer for hyaluronidase contains a buffering agent in order to provide pH of 4.0 to 6.0; 0.001 to 0.5 v/v % of a non-ionic surfactant; and 0.1 to 5 mM of a chelating agent or MgCl2. The liquid formulation has advantages in that it stably maintains its activity for a long period of time and may be easily administered than the conventional formulations.

Abstract: The present invention relates to a composition for inhibiting after-cataract including a hydrophilic sulfasalazine; a high content of hyaluronic acid; and a carrier containing an aqueous solution, and a method of preparing a composition for inhibiting after-cataract including the steps of adding hyaluronic acid powder to a hydrophilized sulfasalazine; and mixing the same with a specific condition.

Abstract: This invention relates to a stable liquid formulation comprising hyaluronidase and a stabilizer for hyaluronidase and more particularly, to a stable liquid formulation by the addition of the stabilizer to the hyaluronidase.

Abstract: There is provided a digital device control system using a smart phone, including a smart phone having an application of a remote control function, a digital device of which on/off of a power supply, channel or volume is controlled according to a signal received from the smart phone, and an IR repeater functioning as a central control unit connected to the smart phone through Bluetooth or Wi-Fi communication and connected to the digital device through a plurality of infrared ray communications in order to remotely control the digital device, and therefore, the digital device can be controlled using the smart phone instead of a remote controller.

Abstract: The present invention relates to a composition for inhibiting after-cataract including a hydrophilic sulfasalazine; a high content of hyaluronic acid; and a carrier containing an aqueous solution, and a method of preparing a composition for inhibiting after-cataract including the steps of adding hyaluronic acid powder to a hydrophilized sulfasalazine; and mixing the same with a specific condition.

Abstract: There is provided a digital device control system using a smart phone, including a smart phone having an application of a remote control function, a digital device of which on/off of a power supply, channel or volume is controlled according to a signal received from the smart phone, and an IR repeater functioning as a central control unit connected to the smart phone through Bluetooth or Wi-Fi communication and connected to the digital device through a plurality of infrared ray communications in order to remotely control the digital device, and therefore, the digital device can be controlled using the smart phone instead of a remote controller.